Biophore is a CDMO headquartered in Hyderabad, India, that is a global provider of contract development and manufacturing of generic APIs and intermediates. The company has a portfolio of APIs that encompasses oncology, contrast media, colored APIs, peptides, hormonals, iron products, and injectables. Biophore currently has over 100 U.S. drug master files (DMFs) and over 20 certifications of suitability (CEPs), along with regulatory filings across Canada, China, South Korea, MENA, and other global markets.